Oric Pharmaceuticals price target raised to $25 from $23 at H.C. Wainwright [Yahoo! Finance]
Oric Pharmaceuticals (NASDAQ:ORIC) had its price target raised by analysts at HC Wainwright from $23.00 to $25.00. They now have a "buy" rating on the stock.
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
Oric Pharmaceuticals (NASDAQ:ORIC) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..